MTP836B - U-clavalenate/trihydrate formulations - Google Patents

U-clavalenate/trihydrate formulations

Info

Publication number
MTP836B
MTP836B MT836A MTP836A MTP836B MT P836 B MTP836 B MT P836B MT 836 A MT836 A MT 836A MT P836 A MTP836 A MT P836A MT P836 B MTP836 B MT P836B
Authority
MT
Malta
Prior art keywords
clavalenate
trihydrate
formulations
trihydrate formulations
Prior art date
Application number
MT836A
Inventor
Patrick John Crowley
Original Assignee
Beccham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MTP836(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beccham Group Ltd filed Critical Beccham Group Ltd
Publication of MTP836B publication Critical patent/MTP836B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MT836A 1977-10-11 1978-10-10 U-clavalenate/trihydrate formulations MTP836B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (1)

Publication Number Publication Date
MTP836B true MTP836B (en) 1979-05-11

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
MT836A MTP836B (en) 1977-10-11 1978-10-10 U-clavalenate/trihydrate formulations

Country Status (24)

Country Link
US (2) US4441609A (en)
JP (1) JPS5476831A (en)
AU (1) AU525089B2 (en)
BE (1) BE870988A (en)
CA (1) CA1105385A (en)
CH (1) CH642258A5 (en)
DE (1) DE2843318A1 (en)
FR (1) FR2405711A1 (en)
GB (1) GB2005538B (en)
HK (1) HK73785A (en)
IE (1) IE47450B1 (en)
IL (1) IL55660A (en)
IT (1) IT1109273B (en)
JO (1) JO984B1 (en)
KE (1) KE3525A (en)
MT (1) MTP836B (en)
MY (1) MY8500996A (en)
NL (1) NL190631B (en)
NZ (1) NZ188497A (en)
PL (1) PL210174A1 (en)
PT (1) PT68600A (en)
SE (2) SE435899B (en)
SG (1) SG34985G (en)
ZA (1) ZA785682B (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
AT353409B (en) * 1975-02-07 1979-11-12 Glaxo Lab Ltd METHOD OF REMOVING CONTAMINATION FROM CLAVULANIC ACID OR THEIR SALT
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
GR70283B (en) * 1979-10-02 1982-09-03 Beecham Group Ltd
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (en) * 1986-01-22 1988-12-23 Adir WATERPROOF PACKAGING IN THE FORM OF ALVEOLAR PLATES ALLOWING FOR GAS EXCHANGES BETWEEN THE ALVEOLES.
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
JPH10503739A (en) * 1994-08-05 1998-04-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Container for moisture sensitive material
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (en) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Medicines used to treat bacterial infections in pediatrics.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
WO1997009042A1 (en) * 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
AT403375B (en) * 1995-11-15 1998-01-26 Biochemie Gmbh METHOD FOR FILLING ALKALINE SALTS OF CLAVULANIC ACID
ITMI952354A1 (en) * 1995-11-16 1997-05-16 Smithkline Beecham Spa PHARMACEUTICAL COMPOSITION
AT407701B (en) * 1996-08-12 2001-05-25 Biochemie Gmbh Mixture which is suitable for direct tableting and contains as essential components amoxicillin trihydrate and the calcium salt of clavulanic acid, and process for preparing this mixture
AT407214B (en) * 1996-03-13 2001-01-25 Biochemie Gmbh Process for the preparation of excipient-free agglomerates of beta-lactam antibiotics
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
PL334976A1 (en) * 1997-02-14 2000-03-27 Smithkline Beecham Lab Pharmaceutic preparations containing amoxycyclin and clavulate
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
WO2001012184A1 (en) * 1999-08-16 2001-02-22 Revaax Pharmaceuticals, Llc Neurotherapeutic composition and method
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
SI20411A (en) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Watersoluble powders for peroral solution and their use
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (en) * 2000-05-30 2004-11-25 Sandoz Ag METHOD FOR DRYING AMOXICILLIN OR AMOXICILLIN-CONTAINING, ORAL, SOLID PHARMACEUTICAL COMPOSITIONS USING A GAS WITH A DEFINED GAS HUMIDITY
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1541140A1 (en) * 2002-08-12 2005-06-15 Kyowa Hakko Kogyo Co., Ltd. Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (en) * 2006-02-17 2007-08-30 Grünenthal GmbH Storage-stable oral dosage form of amoxicillin and clavulanic acid
EP2465609B1 (en) 2007-06-21 2016-12-28 Gen-Probe Incorporated Method for mixing the contents of a detection chamber
EP2214680A4 (en) 2007-10-26 2010-12-29 Rexahn Pharmaceuticals Inc Pharmaceutical formulation of clavulanic acid
CA2758029A1 (en) * 2009-04-29 2011-11-04 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
TR200909787A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Pharmaceutical formulations containing a third generation cephalosporin and clavulanic acid.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus

Also Published As

Publication number Publication date
IT1109273B (en) 1985-12-16
NL7810176A (en) 1979-04-17
MY8500996A (en) 1985-12-31
CA1105385A (en) 1981-07-21
KE3525A (en) 1985-05-31
IE782019L (en) 1979-04-11
US4441609A (en) 1984-04-10
IE47450B1 (en) 1984-03-21
PT68600A (en) 1978-10-01
NZ188497A (en) 1981-05-01
AU525089B2 (en) 1982-10-21
BE870988A (en) 1979-04-03
GB2005538A (en) 1979-04-25
IL55660A (en) 1981-09-13
FR2405711B1 (en) 1982-10-29
SG34985G (en) 1985-11-15
HK73785A (en) 1985-10-04
GB2005538B (en) 1982-05-26
SE435899B (en) 1984-10-29
FR2405711A1 (en) 1979-05-11
JO984B1 (en) 1979-12-01
SE8107592L (en) 1981-12-17
DE2843318A1 (en) 1979-04-12
US4301149A (en) 1981-11-17
SE7810591L (en) 1979-04-12
CH642258A5 (en) 1984-04-13
IT7851415A0 (en) 1978-10-09
IL55660A0 (en) 1978-12-17
JPS6341886B2 (en) 1988-08-19
SE451668B (en) 1987-10-26
AU4050678A (en) 1980-04-17
NL190631B (en) 1994-01-03
PL210174A1 (en) 1980-08-11
ZA785682B (en) 1979-09-26
JPS5476831A (en) 1979-06-19

Similar Documents

Publication Publication Date Title
MTP836B (en) U-clavalenate/trihydrate formulations
AU4201478A (en) Step-stools
NZ187543A (en) 1-acetylenealkylamines
AU3728978A (en) Sulfamoyl-aryl-ketones
AU3526278A (en) L-sucrose
SG82584G (en) 3-indolyl-tertiary butylaminopropanols
GB2005664A (en) 6-deoxyneamines
GB2012308B (en) Electroplatingl
AU3828478A (en) Benzodiazepine-diones
AU3677378A (en) N-acylmethyl-chloroacetanilides
GB2002751A (en) Imidazo-isoquinoline-diones
GB2005971B (en) Tailers
AU3785078A (en) Piperidino-propanols
AU3918778A (en) Beta-substituted-diketones
JPS546386A (en) Hemodynamometer
AU3774978A (en) Butyl-p-benzoylbenzoates
AU3533578A (en) Micro-mill-mixer
AU3355078A (en) Aryl-hexafuranosides
AU4076678A (en) Nd catalystused therein
AU3845478A (en) Isoquinoline-diones
PH15961A (en) D-homosteroids
JPS53103425A (en) Trialkylsulfingold*i*nnlower alkylcarbamoylglucopyranocide
ZA776950B (en) 2-methoxybenzamides
ZA782106B (en) Haloalylmalonamidooxacephalosporins
IL55609A0 (en) N-substututed bentothiazolines